azomycin has been researched along with Soft Tissue Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Abdalah, MA; Budzevich, MM; Bui, MM; Dominguez-Viqueira, W; Gillies, RJ; Huang, S; Jardim-Perassi, BV; Johnson, JO; Martinez, GV; Mu, W; Poleszczuk, J; Reed, DR; Tomaszewski, MR | 1 |
Constantinidou, A; van der Graaf, WTA | 1 |
Chapman, JD; Golberg, LE; Groshar, D; Hoskinson, M; Mannan, RH; McEwan, AJ; Mercer, JR; Parliament, MB; Urtasun, RC; Wiebe, LI | 1 |
Munzenrider, JE | 1 |
Dische, S; Errington, LM; Gray, AJ; Thomlinson, RH | 1 |
1 review(s) available for azomycin and Soft Tissue Neoplasms
Article | Year |
---|---|
Recent advances in radiotherapy.
Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoid Tumor; Elementary Particles; Fast Neutrons; Hot Temperature; Humans; Male; Melanoma; Metronidazole; Neoplasms; Nitroimidazoles; Pancreatic Neoplasms; Prostatic Neoplasms; Protons; Radiation Protection; Radiation Tolerance; Radiation-Sensitizing Agents; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Soft Tissue Neoplasms | 1977 |
1 trial(s) available for azomycin and Soft Tissue Neoplasms
Article | Year |
---|---|
Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours.
Topics: Adult; Cell Survival; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage; Skin Neoplasms; Soft Tissue Neoplasms | 1976 |
3 other study(ies) available for azomycin and Soft Tissue Neoplasms
Article | Year |
---|---|
Deep-learning and MR images to target hypoxic habitats with evofosfamide in preclinical models of sarcoma.
Topics: Animals; Artificial Intelligence; Cell Line, Tumor; Deep Learning; Disease Models, Animal; Doxorubicin; Ecosystem; Female; Humans; Hypoxia; Magnetic Resonance Imaging; Mice; Mice, Inbred C3H; Mice, SCID; Nitroimidazoles; Phosphoramide Mustards; Prodrugs; Sarcoma; Soft Tissue Neoplasms; Xenograft Model Antitumor Assays | 2021 |
The fate of new fosfamides in phase III studies in advanced soft tissue sarcoma.
Topics: Antineoplastic Agents, Alkylating; Clinical Trials, Phase III as Topic; Evidence-Based Medicine; Humans; Neoplasm Staging; Nitroimidazoles; Phosphoramide Mustards; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Time Factors; Treatment Outcome | 2017 |
Imaging tumor hypoxia and tumor perfusion.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Glioblastoma; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Nitroimidazoles; Organotechnetium Compounds; Oximes; Sarcoma; Soft Tissue Neoplasms; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1993 |